- Home
- LAW vs AQST Comparison
LAW vs AQST Comparison
Compare LAW & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAW
- AQST
- Stock Information
- Founded
- LAW 2013
- AQST 2004
- Country
- LAW United States
- AQST United States
- Employees
- LAW N/A
- AQST N/A
- Industry
- LAW Computer Software: Prepackaged Software
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- LAW Technology
- AQST Health Care
- Exchange
- LAW Nasdaq
- AQST Nasdaq
- Market Cap
- LAW 259.6M
- AQST 272.9M
- IPO Year
- LAW 2021
- AQST 2018
- Fundamental
- Price
- LAW $4.40
- AQST $3.31
- Analyst Decision
- LAW Hold
- AQST Strong Buy
- Analyst Count
- LAW 3
- AQST 6
- Target Price
- LAW $6.17
- AQST $10.67
- AVG Volume (30 Days)
- LAW 211.2K
- AQST 1.6M
- Earning Date
- LAW 08-07-2025
- AQST 08-05-2025
- Dividend Yield
- LAW N/A
- AQST N/A
- EPS Growth
- LAW N/A
- AQST N/A
- EPS
- LAW N/A
- AQST N/A
- Revenue
- LAW $145,923,000.00
- AQST $54,228,000.00
- Revenue This Year
- LAW $6.09
- AQST N/A
- Revenue Next Year
- LAW $6.27
- AQST $45.71
- P/E Ratio
- LAW N/A
- AQST N/A
- Revenue Growth
- LAW 3.84
- AQST 5.29
- 52 Week Low
- LAW $3.31
- AQST $2.12
- 52 Week High
- LAW $6.64
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- LAW 62.19
- AQST 54.11
- Support Level
- LAW $4.30
- AQST $3.13
- Resistance Level
- LAW $4.49
- AQST $3.46
- Average True Range (ATR)
- LAW 0.16
- AQST 0.24
- MACD
- LAW 0.02
- AQST -0.04
- Stochastic Oscillator
- LAW 89.57
- AQST 17.52
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.